Riskpilot← Back to searchSign inGet full accessLÆGEHUSET I NØRREGADE. HERNING. ApS
APSActiveCVR 32086012Nørregade 10, 2.Rental and operating of own or leased real estate · NACE 6820Est. 19740 employees
Revenue 2025
DKK 315K
-16% vs 2024
EBITDA margin
100.0%
-16% vs 2024
Equity ratio
74.5%
Financial strength
Net profit 2025
DKK 220K
-16% vs 2024
| Revenue | DKK 315K | -16% |
| EBITDA | DKK 315K | -16% |
| Net profit | DKK 220K | -16% |
| Total assets | DKK 9,8M | +2% |
| Equity | DKK 7,3M | +3% |
| Employees | 0 | — |
Legal name
LÆGEHUSET I NØRREGADE. HERNING. ApS
CVR number
32086012
Legal form
Anpartsselskab
NACE code
6820 · Rental and operating of own or leased real estate
Founded
7. oktober 1974
Share capital
DKK 3.750.000
Employees
0
VAT registered
No
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af et medlem af bestyrelsen i forening med en direktør
Company purpose
Selskabets formål er at udøve erhvervsmæssig drift af ejendommen "Lægehuset i Nørregade", ved udlejning til lægekonsultationslokaler, forretningslokaler etc
Address
Nørregade 10, 2.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 369 | 418 | 403 | 373 | 315 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 369 | 418 | 1.703 | 373 | 315 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 369 | 418 | 1.703 | 373 | 315 |
| Net financials | -55 | -53 | 1.255 | -36 | -33 |
| Profit before tax | 314 | 365 | 1.658 | 336 | 282 |
| Tax | 70 | 80 | 365 | 76 | 62 |
| Net profit | 244 | 284 | 1.293 | 261 | 220 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7.866 | 8.149 | 9.593 | 9.653 | 9.800 |
| Equity | 5.243 | 5.527 | 6.820 | 7.080 | 7.300 |
| Long-term debt | 2.190 | 2.079 | 1.966 | 1.849 | 1.732 |
| Short-term debt | 318 | 347 | 306 | 222 | 267 |
| Total debt | 2.507 | 2.426 | 2.272 | 2.071 | 1.999 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20212025
Equity ratio
74.5%
This company
38.2%
Market median
+95% vs market
20212025
Return on equity
3.0%
This company
18.4%
Market median
-84% vs market
20212025
Net profit margin
69.8%
This company
8.1%
Market median
+762% vs market
20212025
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20212025
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
CE Management | Management | 1974 – 2007 |
| Name | Role | Member since |
|---|---|---|
| Former (9) | ||
| Board of Directors | 2003 – 2004 | |
| Chairman | 1974 – 1992 | |
| Chairman | 1974 – 1998 | |
| Chairman | 2013 – 2017 | |
| Board of Directors | 1974 – 2003 | |
| Board of Directors | 2024 – 2025 | |
| Board of Directors | 1998 – 2002 | |
| Board of Directors | 1974 – 1998 | |
| Board of Directors | 2002 – 2011 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 5–9.99% | 5–9.99% | 2021 | |
| Individual | 5–9.99% | 5–9.99% | 2003 | |
| Individual | 5–9.99% | 5–9.99% | 2025 | |
| Individual | 5–9.99% | 5–9.99% | 1998 | |
| Individual | 5–9.99% | 5–9.99% | 2008 | |
| Individual | 5–9.99% | 5–9.99% | 2006 | |
| Individual | 5–9.99% | 5–9.99% | 2001 | |
| Individual | 5–9.99% | 5–9.99% | 2000 | |
| Individual | 5–9.99% | 5–9.99% | 2013 | |
| Individual | 5–9.99% | 5–9.99% | 2019 | |
| Company | 5–9.99% | 5–9.99% | 2017 | |
| Individual | 5–9.99% | 5–9.99% | 2016 | |
| Individual | 5–9.99% | 5–9.99% | 2008 | |
| Individual | 5–9.99% | 5–9.99% | 1987 | |
| Individual | 5–9.99% | 5–9.99% | 1988 | |
| Individual | 5–9.99% | 5–9.99% | 2008 | |
| Individual | 5–9.99% | 5–9.99% | 1990 | |
| Individual | 5–9.99% | 5–9.99% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LÆGEHUSET I NØRREGADE. HERNING. ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claus Erik Markvardsen | Management | 0 companies |
| Viggo Højlund Mogensen | Board of Directors | 0 companies |
| Georg Jørgen Becker | Chairman | 0 companies |
| Nils Thorsen | Chairman | 0 companies |
| Karen Jepsen | Chairman | 0 companies |
| Torben Sandager | Board of Directors | 0 companies |
| Peter Johansen | Board of Directors | 0 companies |
| Pia Madsen | Board of Directors | 0 companies |
| Erik Wellendorf | Board of Directors | 0 companies |
| Lars Kristian Holm | Board of Directors | 0 companies |